137 related articles for article (PubMed ID: 21269600)
21. The role of thermogenesis in antipsychotic drug-induced weight gain.
Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
[TBL] [Abstract][Full Text] [Related]
22. A model for antipsychotic-induced obesity in the male rat.
Minet-Ringuet J; Even PC; Lacroix M; Tomé D; de Beaurepaire R
Psychopharmacology (Berl); 2006 Sep; 187(4):447-54. PubMed ID: 16783538
[TBL] [Abstract][Full Text] [Related]
23. An animal model of antipsychotic-induced weight gain.
Arjona AA; Zhang SX; Adamson B; Wurtman RJ
Behav Brain Res; 2004 Jun; 152(1):121-7. PubMed ID: 15135975
[TBL] [Abstract][Full Text] [Related]
24. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
Cooper GD; Harrold JA; Halford JC; Goudie AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
[TBL] [Abstract][Full Text] [Related]
25. Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.
Davoodi N; Kalinichev M; Korneev SA; Clifton PG
Psychopharmacology (Berl); 2009 May; 203(4):693-702. PubMed ID: 19052729
[TBL] [Abstract][Full Text] [Related]
26. Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human.
Pouzet B; Mow T; Kreilgaard M; Velschow S
Pharmacol Biochem Behav; 2003 Apr; 75(1):133-40. PubMed ID: 12759121
[TBL] [Abstract][Full Text] [Related]
27. Estrogen replacement reverses olanzapine-induced weight gain and hepatic insulin resistance in ovariectomized diabetic rats.
Park S; Hong SM; Ahn IL; Kim DS; Kim SH
Neuropsychobiology; 2010; 61(3):148-61. PubMed ID: 20173353
[TBL] [Abstract][Full Text] [Related]
28. Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats.
Zhang Q; He M; Deng C; Wang H; Lian J; Huang XF
Int J Neuropsychopharmacol; 2014 May; 17(5):807-18. PubMed ID: 24468236
[TBL] [Abstract][Full Text] [Related]
29. The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats.
Lian J; Deng C
Pharmacol Biochem Behav; 2020 Apr; 191():172878. PubMed ID: 32112786
[TBL] [Abstract][Full Text] [Related]
30. Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats.
He M; Zhang Q; Deng C; Wang H; Lian J; Huang XF
Psychoneuroendocrinology; 2014 Apr; 42():153-64. PubMed ID: 24636512
[TBL] [Abstract][Full Text] [Related]
31. Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution.
van der Zwaal EM; Luijendijk MC; Adan RA; la Fleur SE
Eur J Pharmacol; 2008 May; 585(1):130-6. PubMed ID: 18378227
[TBL] [Abstract][Full Text] [Related]
32. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
[TBL] [Abstract][Full Text] [Related]
33. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Raskind MA; Burke BL; Crites NJ; Tapp AM; Rasmussen DD
Neuropsychopharmacology; 2007 Feb; 32(2):284-8. PubMed ID: 16710316
[TBL] [Abstract][Full Text] [Related]
34. A parametric analysis of olanzapine-induced weight gain in female rats.
Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
[TBL] [Abstract][Full Text] [Related]
35. Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatin.
Liu X; Feng X; Deng C; Liu L; Zeng Y; Hu CH
BMC Pharmacol Toxicol; 2020 Jun; 21(1):48. PubMed ID: 32605639
[TBL] [Abstract][Full Text] [Related]
36. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.
Weston-Green K; Huang XF; Lian J; Deng C
Eur Neuropsychopharmacol; 2012 May; 22(5):364-73. PubMed ID: 21982116
[TBL] [Abstract][Full Text] [Related]
37. Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine.
Zugno AI; Barcelos M; Oliveira Ld; Canever L; Luca RD; Fraga DB; Matos MP; Rezin GT; Scaini G; Búrigo M; Streck EL; Quevedo J
Braz J Psychiatry; 2012 Jun; 34(2):168-75. PubMed ID: 22729413
[TBL] [Abstract][Full Text] [Related]
38. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
[TBL] [Abstract][Full Text] [Related]
39. Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat.
Hunt HJ; Ray NC; Hynd G; Sutton J; Sajad M; O'Connor E; Ahmed S; Lockey P; Daly S; Buckley G; Clark RD; Roe R; Blasey C; Belanoff J
Bioorg Med Chem Lett; 2012 Dec; 22(24):7376-80. PubMed ID: 23131342
[TBL] [Abstract][Full Text] [Related]
40. Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.
Yoon S; Noh JS; Choi SY; Baik JH
Biochem Biophys Res Commun; 2010 Mar; 393(2):235-41. PubMed ID: 20117094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
